SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

ICP is drawing attention for a recent rebound and renewed attempts to break through technical resistance, prompting bullish breakout talk alongside doubts about weak volume and repeated rejections. The debate also reflects broader confidence in its decentralized-computing and AI infrastructure thesis versus frustration over slow adoption and underwhelming price action.

iShares Trust - iShares 7-10 Year Treasury Bond ETF

iShares 7-10 Year Treasury Bond ETF

Rising Treasury yields and expectations for rates to stay higher for longer are driving discussion, with traders citing inflation, Fed policy uncertainty and term-premium concerns as pressure on IEF. Sentiment is mostly bearish, though some see the selloff as an overreaction and expect a bond rebound; the debate also includes whether stocks can remain resilient as yields rise.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget is drawing attention as traders revisit its dramatic short squeeze and subsequent reversal, with some speculating about another squeeze while bears point to heavy debt, earnings concerns, and further downside. The discussion reflects competing views on volatile trading rather than a clearly established new catalyst.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

XLV is drawing attention for healthcares relative strength and renewed defensive-sector rotation, alongside a rebound from technical support that traders view as keeping the bullish trend intact. Some remain cautious about a pullback or argue the rotation may be short-lived.

the cat on Base  community-run home for $BASECAT

Basecat

Basecats Coinbase availability and a sharp volatile move are driving attention, with traders discussing a possible reversal and renewed buying. Others caution that the move may be a pump-and-dump, pointing to persistent selling and uncertainty about a durable recovery.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

GameStops roughly 10% stake in eBay and its takeover pursuit dominate discussion, with traders debating whether the bid could lead to a deal or partnershipor be withdrawn. Some see the stake as a potential catalyst, while skeptics question the deals feasibility and warn about financing and dilution risks.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is drawing attention for its breakout to fresh highs, with traders pointing to positive pipeline and regulatory developmentsincluding Parkinsons treatment approval and encouraging lymphoma trial dataas support for the stock. Sentiment is mostly bullish, though some traders warn of consolidation and false-breakout risk.

Ethena

ENAs rally is being tied by traders to growing USDe adoption and the approved fee-switch framework, which could direct protocol revenue to ENA buybacks once a supply threshold is reached. Bullish posts point to rising volume and ecosystem expansion, while others warn that token unlocks, potential dilution and profit-taking could weigh on the price; buybacks have not yet begun.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X ETF

Gold and junior-miner momentum is the main focus, with traders linking interest in JNUG to safe-haven demand and concerns about inflation, currency debasement, and government debt. Sentiment is split between bullish dip-buying and warnings that the leveraged ETF can swing sharply and lose value during pullbacks.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

A bearish Barclays downgrade has intensified JOBYs selloff, with traders also focused on a jury verdict in a trade-secrets case and concerns about cash burn and manufacturing capacity. Some view the decline as an overreaction and are accumulating shares, while others see the legal costs, insider selling and long path to FAA certification as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$OBMP  I&#39;ve been trying to buy this stock all week but my order won&#39;t fill.

Sbizzle

StockTwits For Android 

Nickjames

StockTwits Web

OncBioMune Pharmaceuticals Inc

  I've been trying to buy this stock all week but my order won't fill.

Claudia

@Pyctjh It&#39;s unsolicited quote only, you have to call your broker directly if you want to buy. 

That company market cap has been inflated severly by the issuance of 5B shares from the conversion of the Series D1 Preferred shares in June 2020, after the acquisition of &quot;Avant&quot; .

https://www.otcmarkets.com/filing/html?id=15247906&amp;guid=4Ohwke2PQFqo7bh

They mentioned Avant being in commercial stage, but the revenue for June 2021 is very low compare to current market cap (280k$ vs 4.33B$ market cap!)

Avant is a commercial-stage precision medicine and molecular data-generating company that focuses on the development and commercialization of a series of patented, proprietary data-generating assays that may provide important actionable information for physicians and patients, as well as biopharmaceutical companies, in the areas of oncology.

That&#39;s their website, the one on OTCmarkets isn&#39;t correct.

https://theralink.com/

Otcmarkets

THERALINK ENABLES CLEAR DECISION MAKING FOR AN INDIVIDUAL PATIENT`S CANCER TREATMENT USING PREDICTIVE PROTEIN BIOMARKERS

Theralink

 It's unsolicited quote only, you have to call your broker directly if you want to buy. 

That company market cap has been inflated severly by the issuance of 5B shares from the conversion of the Series D1 Preferred shares in June 2020, after the acquisition of "Avant" .





They mentioned Avant being in commercial stage, but the revenue for June 2021 is very low compare to current market cap (280k$ vs 4.33B$ market cap!)

Avant is a commercial-stage precision medicine and molecular data-generating company that focuses on the development and commercialization of a series of patented, proprietary data-generating assays that may provide important actionable information for physicians and patients, as well as biopharmaceutical companies, in the areas of oncology.

That's their website, the one on OTCmarkets isn't correct.

